Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.
We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
– Update on FDA Inspection of Buena Facility – Assessing New Growth Opportunities in Injectables – Conference Call to Be...Learn More
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021
BUENA, N.J. , Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jer...Learn More
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
Scheduled to Reconvene on July 21, 2021 Company Urgently Encourages Stockholders to Vote BUENA, N.J. , June 30, 2021 (GL...Learn More